Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q4 2024 Earnings Call Transcript February 25, 2025
Arcutis Biotherapeutics, Inc. beats earnings expectations. Reported EPS is $-0.09, expectations were $-0.28.
Operator: Good day and welcome to Arcutis Biotherapeutics 2024 Fourth Quarter and Full Year Financial Results Conference Call. At this time all participants are in a listen-only mode. After the speakers’ presentation there will be a question-and-answer session. [Operator Instructions] Please...
